Acute myeloid leukemia: conventional cytogenetics, FISH, and moleculocentric methodologies.
Clin. Lab. Med., Dec;31(4):659-86, x (2011)
B cells behaving badly: a better basis to behold belligerence in B-cell lymphomas.
Hematology Am Soc Hematol Educ Program., 2011:330-5 (2011)
T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia.
Sci Transl Med., Aug;3(95):95ra73 (2011)
A comparative analysis of molecular genetic and conventional cytogenetic detection of diagnostically important translocations in more than 400 cases of acute leukemia, highlighting the frequency of false-negative conventional cytogenetics.
Am. J. Clin. Pathol., Jun;135(6):921-8 (2011)
Minimal residual disease testing to predict relapse following transplant for AML and high-grade myelodysplastic syndromes.
Expert Rev. Mol. Diagn., May;11(4):361-6 (2011)
Molecular diagnosis of acute myeloid leukemia.
Expert Rev. Mol. Diagn., Nov;10(8):993-1012 (2010)
IMP-3 is differentially expressed in normal and neoplastic lymphoid tissue.
Hum. Pathol., Dec;40(12):1699-705 (2009)
Crystal-storing histiocytosis in plasma cell myeloma.
Am. J. Hematol., Jun;85(6):444-5 (2010)
Flow-cytometric analysis of peripheral blood neutrophils: a simple, objective, independent and potentially clinically useful assay to facilitate the diagnosis of myelodysplastic syndromes.
Am. J. Hematol., Jul;79(3):243-5 (2005)
Therapy-associated lymphoid proliferations.
Adv Anat Pathol., May;18(3):199-205 (2011)
Molecular diagnosis in lymphoma.
Curr. Hematol. Rep., Jul;4(4):313-23 (2005)
Immunoglobulin and T-cell receptor gene rearrangements: minding your B's and T's in assessing lineage and clonality in neoplastic lymphoproliferative disorders.
J Mol Diagn., Sep;8(4):426-9; quiz 526-7 (2006)
Igbeta(CD79b) mRNA expression in chronic lymphocytic leukaemia cells correlates with immunoglobulin heavy chain gene mutational status but does not serve as an independent predictor of clinical severity.
Am. J. Hematol., Aug;82(8):712-20 (2007)
Molecular diagnosis and monitoring in the clinical management of patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors.
Am. J. Hematol., Apr;83(4):296-302 (2008)
Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell.
Expert Rev. Mol. Diagn., Nov;7(6):805-20 (2007)
ZAP70 expression assessed by immunohistochemistry on peripheral blood: a simple prognostic assay for patients with chronic lymphocytic leukemia.
Appl. Immunohistochem. Mol. Morphol., Dec;15(4):471-6 (2007)
Sudden extramedullary T-lymphoblastic blast crisis in chronic myelogenous leukemia: a nonrandom event associated with imatinib?
Am. J. Clin. Pathol., Apr;129(4):639-48 (2008)
Nucleophosmin (NPM1) mutations in acute myeloid leukemia: an ongoing (cytoplasmic) tale of dueling mutations and duality of molecular genetic testing methodologies.
J Mol Diagn., May;10(3):198-202 (2008)
Malleable immunoglobulin genes and hematopathology - the good, the bad, and the ugly: a paper from the 2007 William Beaumont hospital symposium on molecular pathology.
J Mol Diagn., Sep;10(5):396-410 (2008)
Role of molecular studies in the classification of lymphoma.
Expert Rev. Mol. Diagn., Jan;4(1):83-97 (2004)